130 related articles for article (PubMed ID: 31538980)
1. 5-Fluorouracil Infiltrations and Ambulatory Pumps: Education, Prevention, and Management Considerations.
Bostelman C
Clin J Oncol Nurs; 2019 Oct; 23(5):537-539. PubMed ID: 31538980
[TBL] [Abstract][Full Text] [Related]
2. Advanced colorectal cancer: quality of life and toxicity in patients after weekly 24-hour continuous infusions of biomodulated 5-fluorouracil.
Bogliolo G; Pannacciulli I; Desalvo L; Barsotti B; Lerza R; Mencoboni M; Arboscello E
Anticancer Res; 2000; 20(1B):501-4. PubMed ID: 10769713
[TBL] [Abstract][Full Text] [Related]
3. Reversible cardiogenic shock following 5-fluorouracil infusion.
Ferté C; Gomez Roca C; Loriot Y; Bahleda R; Moldovan C; Cohen A; Izzedine H; Soria JC; Ederhy S
Invest New Drugs; 2010 Aug; 28(4):531-3. PubMed ID: 19499187
[TBL] [Abstract][Full Text] [Related]
4. Angina induced by 5-fluorouracil infusion in a patient with normal coronaries.
Tajik R; Saadat H; Taherkhani M; Movahed MR
Am Heart Hosp J; 2010; 8(2):E111-2. PubMed ID: 21928176
[TBL] [Abstract][Full Text] [Related]
5. Continuous infusion of chemotherapy: focus on 5-fluorouracil and fluorodeoxyuridine.
Poorter RL; Bakker PJ; Veenhof CH
Pharm World Sci; 1998 Apr; 20(2):45-59. PubMed ID: 9584337
[TBL] [Abstract][Full Text] [Related]
6. Establishing a programme for continuous ambulatory infusion chemotherapy.
Cox K; Visintin L; Kovac S; Childs A; Kelleher H; Murray B; White G; Storey D; Findlay M
Aust N Z J Med; 1997 Dec; 27(6):680-4. PubMed ID: 9483236
[TBL] [Abstract][Full Text] [Related]
7. Desensitization to 5-fluorouracil.
Eppinger T; Sperber K
Allergy Asthma Proc; 1999; 20(3):189-91. PubMed ID: 10389552
[TBL] [Abstract][Full Text] [Related]
8. A phase I-II trial of five-day continuous intravenous infusion of 5-fluorouracil delivered at circadian rhythm modulated rate in patients with metastatic colorectal cancer.
Lévi F; Soussan A; Adam R; Caussanel JP; Metzger G; Jasmin C; Bismuth H; Smolensky M; Misset JL
J Infus Chemother; 1995; 5(3 Suppl 1):153-8. PubMed ID: 8528977
[TBL] [Abstract][Full Text] [Related]
9. Accidental Overdoses Involving Fluorouracil Infusions.
Shastay A
Home Healthc Now; 2017 Apr; 35(4):226-228. PubMed ID: 28353515
[No Abstract] [Full Text] [Related]
10. The French experience with infusional 5-fluorouracil in advanced colorectal cancer.
de Gramont A; Louvet C; Krulik M
J Infus Chemother; 1996; 6(3):133-6. PubMed ID: 9229324
[TBL] [Abstract][Full Text] [Related]
11. A case of acute myocardial infarction during 5-fluorouracil infusion.
Canale ML; Camerini A; Stroppa S; Porta RP; Caravelli P; Mariani M; Balbarini A; Ricci S
J Cardiovasc Med (Hagerstown); 2006 Nov; 7(11):835-7. PubMed ID: 17060812
[TBL] [Abstract][Full Text] [Related]
12. A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancers.
Yeh KH; Cheng AL; Lin MT; Hong RL; Hsu CH; Lin JF; Chang KJ; Lee PH; Chen YC
Anticancer Res; 1997; 17(5B):3867-71. PubMed ID: 9427794
[TBL] [Abstract][Full Text] [Related]
13. Fluorouracil: dosing errors with infusion pumps.
Prescrire Int; 2014 Oct; 23(153):242. PubMed ID: 25969854
[No Abstract] [Full Text] [Related]
14. Docetaxel in combination with fluorouracil for advanced solid tumors.
Burris HA
Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):50-2. PubMed ID: 9364544
[TBL] [Abstract][Full Text] [Related]
15. 5-methyltetrahydrofolate for biochemical modulation of fluorouracil (FU) in patients with advanced colorectal cancer: a randomized phase I-II study of two different FU administration schedules.
Hejna M; Kornek GV; Raderer M; Valencak J; Weinländer G; Fiebiger W; Miholic J; Scheithauer W
Ann Oncol; 1998 Dec; 9(12):1309-14. PubMed ID: 9932161
[TBL] [Abstract][Full Text] [Related]
16. Long-term continuous 5-fluorouracil infusion in patients with advanced head and neck cancer.
Sørensen P; Andersen LJ; Hansen O; Bastholt L
Acta Oncol; 1999; 38(8):1043-5. PubMed ID: 10665760
[TBL] [Abstract][Full Text] [Related]
17. Continuous infusion 5-fluorouracil as first-line therapy for metastatic breast cancer.
Chu L; Sutton LM; Peterson BL; Havlin KA; Winer EP
J Infus Chemother; 1996; 6(4):211-6. PubMed ID: 9229318
[TBL] [Abstract][Full Text] [Related]
18. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
Klaassen U; Wilke H; Seeber S
Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
[TBL] [Abstract][Full Text] [Related]
19. Comparative pharmacokinetic study of continuous venous infusion fluorouracil and oral fluorouracil with eniluracil in patients with advanced solid tumors.
Adjei AA; Reid JM; Diasio RB; Sloan JA; Smith DA; Rubin J; Pitot HC; Alberts SR; Goldberg RM; Hanson LJ; Atherton P; Ames MM; Erlichman C
J Clin Oncol; 2002 Mar; 20(6):1683-91. PubMed ID: 11896120
[TBL] [Abstract][Full Text] [Related]
20. A phase I trial of 5-day chronomodulated infusion of 5-fluorouracil and 1-folinic acid in patients with metastatic colorectal cancer.
Garufi C; Lévi F; Aschelter AM; Pace R; Giunta S; Nisticò C; Gallà DA; Silecchia GF; Franchi F; Narduzzi C; Terzoli E
Eur J Cancer; 1997 Sep; 33(10):1566-71. PubMed ID: 9389916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
